CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026)
CRISPR Therapeutics AG's (CRSP) quarterly EPS (Basic) came in at -$1.28 in Q1 2026, up 18.99% year-on-year from -$1.08 in Q1 2025, and up 5.19% quarter-over-quarter from -$1.35 in Q4 2025.
CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has disclosed EPS (Basic) across 12 years of filings, most recently posting -$1.28 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.28, up 18.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.2 (down 37.78% YoY), and the FY2025 annual result was -$6.47, down 49.08% from the prior year.
- EPS (Basic) came in at -$1.28 for Q1 2026 at CRISPR Therapeutics AG, up from -$1.35 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.13 in Q4 2023 to a low of -$2.4 in Q2 2022.
- The 5-year median for EPS (Basic) is -$1.4 (2022), against an average of -$1.32.
- Across the five-year window, EPS (Basic) soared 180.71% in 2023 and plunged 221.43% in 2025, its largest moves.
- CRISPR Therapeutics AG's EPS (Basic) stood at -$1.4 in 2022, then jumped by 180.71% to $1.13 in 2023, then plunged by 137.17% to -$0.42 in 2024, then slumped by 221.43% to -$1.35 in 2025, then advanced by 5.19% to -$1.28 in 2026.
- The last three EPS (Basic) figures came in at -$1.28 (Q1 2026), -$1.35 (Q4 2025), and -$1.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | CRISPR Therapeutics AG | 5.21 Bn | 2.76 Bn | - | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.35 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -2.40 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | -0.42 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.43 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -1.40 |
| Sep 30, 2022 | -2.24 |
| Jun 30, 2022 | -2.40 |
| Mar 31, 2022 | -2.32 |
| Dec 31, 2021 | -1.88 |
| Sep 30, 2021 | -1.67 |
| Jun 30, 2021 | 10.01 |